Cargando…

Prevention of platelet aggregation and arterial thrombosis using a modified Shenzhu Guanxin Formula

OBJECTIVE: Modified Shenzhu Guanxin Formula (mSGF) has beneficial effects in coronary artery disease. Previously, we found that mSGF inhibited platelet aggregation in rats. In the present study we further investigated the antiplatelet and antithrombotic activities of mSGF in rats. METHODS: Rats were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Manting, Wu, Huanlin, Wu, Jianping, Chen, Qiuxiong, Zou, Dezhi, Xu, Danping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Pre-Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586491/ https://www.ncbi.nlm.nih.gov/pubmed/33086881 http://dx.doi.org/10.1177/0300060520941326

Ejemplares similares

The efficacy and safety of Shenzhu Guanxin Recipe Granules for the treatment of patients with coronary artery disease: protocol for a double-blind, randomized controlled trial
por: Jin, Xiao, et al.
Publicado: (2019)

Naringenin Inhibits Platelet Activation and Arterial Thrombosis Through Inhibition of Phosphoinositide 3-Kinase and Cyclic Nucleotide Signaling
por: Huang, Manting, et al.
Publicado: (2021)

Protective effect of Guanxin Danshen formula on myocardial ischemiareperfusion injury in rats
por: Li, Lanfang, et al.
Publicado: (2023)

The Chinese Herbal Formula Shenzhu Tiaopi Granule Results in Metabolic Improvement in Type 2 Diabetic Rats by Modulating the Gut Microbiota
por: Zhao, Jindong, et al.
Publicado: (2019)

Gut microbial modulation in the treatment of chemotherapy-induced diarrhea with Shenzhu Capsule
por: Wang, Jing, et al.
Publicado: (2019)

Highly oxidized low-density lipoprotein does not facilitate platelet aggregation
por: Miyazaki, Akari, et al.
Publicado: (2020)

Hesperetin inhibits foam cell formation and promotes cholesterol efflux in THP-1-derived macrophages by activating LXRα signal in an AMPK-dependent manner
por: Chen, Xuanjing, et al.
Publicado: (2021)

Platelet Aggregation Tests and Thrombosis
por: O'Brien, J. R.
Publicado: (1969)

Guanxin V Acts as an Antioxidant in Ventricular Remodeling
por: Liang, Bo, et al.
Publicado: (2022)

Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs
por: Feng, Wuwen, et al.
Publicado: (2018)

Effect of Guanxin V in animal model of acute myocardial infarction
por: Zhang, Xiaoxiao, et al.
Publicado: (2021)

Salvianolic acid B protects against myocardial ischaemia-reperfusion injury in rats via inhibiting high mobility group box 1 protein expression through the PI3K/Akt signalling pathway
por: Liu, Hanqing, et al.
Publicado: (2019)

Chinese medicinal formula Guanxin Shutong capsule protects the heart against oxidative stress and apoptosis induced by ischemic myocardial injury in rats
por: CAO, YANJUN, et al.
Publicado: (2014)

Structure of shear-induced platelet aggregated clot formed in an in vitro arterial thrombosis model
por: Kim, Dongjune A., et al.
Publicado: (2022)

TRAIL inhibits platelet-induced colorectal cancer cell invasion
por: Wu, Li-Sha, et al.
Publicado: (2019)

Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation
por: Bonacina, F., et al.
Publicado: (2016)

Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation
por: Jamasbi, Janina, et al.
Publicado: (2016)

Platelet-T cell aggregates in lung cancer patients: Implications for thrombosis
por: Meikle, Claire K., et al.
Publicado: (2020)

Effect of alteplase on platelet function and receptor expression
por: Lu, Jun, et al.
Publicado: (2019)

Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics
por: Wang, Dan, et al.
Publicado: (2021)

Effects of Danshensu on Platelet Aggregation and Thrombosis: In Vivo Arteriovenous Shunt and Venous Thrombosis Models in Rats
por: Yu, Chen, et al.
Publicado: (2014)

Guanxin V attenuates myocardial ischaemia reperfusion injury through regulating iron homeostasis
por: Zhou, Fuqiong, et al.
Publicado: (2022)

Neutrophils promote venular thrombosis by shaping the rheological environment for platelet aggregation
por: Puhr-Westerheide, Daniel, et al.
Publicado: (2019)

Establishing quality indicators for pre-hospital advanced airway management: a modified nominal group technique consensus process
por: Kottmann, Alexandre, et al.
Publicado: (2022)

Yangxin granules alleviate doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis mediated by AKT/GSK3β/β-catenin signaling
por: Ren, Dezhi, et al.
Publicado: (2020)

L'Europe aura en 1958 son laboratoire "atomique" pour 6 milliards. Il sera édifié á Geneve
Publicado: (1951)

Europe laboratory may get five-billion-volt cyclotron
por: Humphreys, W J
Publicado: (1951)

A la conférence atomique européenne l'Angleterre propose d'installer à Liverpool le laboratoire nucléaire commun
Publicado: (1951)

Le premier super-cosmotron de trente milliards d'electrons-volts sera construit en Europe
por: Dauzats, C
Publicado: (1952)

Energia nucleare a scopi di pace
por: Tonella, G
Publicado: (1952)

Atomic research plan in Europe
Publicado: (1952)

Genève deviendra-t-elle ville atomique?
por: Le Grand Roy, R
Publicado: (1952)

Letters to the Editor. Co-operation in Nuclear Science
por: De Madariaga, S
Publicado: (1952)

Le Laboratoire européen de recherches nucléaires aura son siège à Genève
Publicado: (1952)

Genf - Sitz der Atomzentrale Europas?
Publicado: (1952)

Atom centre plan divides Europe
Publicado: (1952)

Das europäische Laboratorium für Kernphysik
Publicado: (1952)

Europe forms atom body. Eleven nations to pool funds for research program
Publicado: (1952)

Britain stays out of atom talks
Publicado: (1952)

L'Europe aura son laboratoire nucléaire
Publicado: (1952)

Cannot write session to /tmp/vufind_sessions/sess_rkg3k20fg1s038n7651bviesjk